Management of Idiopathic Macular Telangiectasia Type 2
Abstract Macular telangiectasia type 2 (MacTel) is a relatively rare disease without established treatments. Although MacTel was previously considered a primarily vascular condition, the thinking on its pathogenesis has shifted to it now being considered principally a neurodegenerative disease. This...
Main Authors: | Alireza Khodabande, Ramak Roohipoor, Javad Zamani, Masoud Mirghorbani, Hamidreza Zolfaghari, Shahab Karami, Bobeck S. Modjtahedi |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2019-02-01
|
Series: | Ophthalmology and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s40123-019-0170-1 |
Similar Items
-
Idiopathic Macular Telangiectasia Type 1 treated with Intravitreal Ranibizumab and Laser Photocoagulation
by: Inês Martins de Almeida, et al.
Published: (2015-09-01) -
Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia
by: Berger TA, et al.
Published: (2021-03-01) -
A complete clinical review of idiopathic macular telangiectasia
by: P Jayasri, et al.
Published: (2023-01-01) -
Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
by: John Moir, et al.
Published: (2022-07-01) -
Long-term follow-up in macular telangiectasia type 1: Clinical image
by: Juliana A Rio, et al.
Published: (2024-01-01)